Methylation of estrogen receptor alpha and uses thereof

C - Chemistry – Metallurgy – 12 – Q

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12Q 1/68 (2006.01) A61K 38/12 (2006.01) A61K 38/15 (2006.01) C07H 21/02 (2006.01) C07H 21/04 (2006.01)

Patent

CA 2648160

Methods for diagnosis, prognosis, and treatment of cancer based on the methylation status of the ER-.alpha. gene promoter are disclosed. Methylation of the ER-.alpha. gene promoter is indicative of cancer and unfavorable prognosis. The cancer can be treated with a demethylation agent.

L'invention concerne des procédés de diagnostic, de pronostic, et de traitement du cancer basés sur l'état de méthylation du promoteur du gène ER-.alpha.. La méthylation du promoteur du gène ER-.alpha. indique le cancer ou un pronostic défavorable. Le cancer peut être traité avec un agent de déméthylation.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Methylation of estrogen receptor alpha and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methylation of estrogen receptor alpha and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methylation of estrogen receptor alpha and uses thereof will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1426253

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.